A Branford laboratory and its owner have agreed to pay $145,720 to settle allegations they concealed ties to a related lab under fraud investigation in order to gain approval to participate in Connecticut’s Medicaid program.
The settlement, announced Tuesday by U.S. Attorney David X. Sullivan, resolves claims against Coastal Diagnostics LLC and its owner, Tricia Conroy.
According to federal and state investigators, Conroy falsely stated on a March 2024 Medicaid enrollment application that neither she nor other company officials had family or business ties to any current or recent Medicaid provider.
Investigators said that was untrue. Conroy’s husband owned Genco Lab LLC, another laboratory operating at the same Branford address, and Conroy served as its chief operating officer.
At the time, Genco Lab was under a Medicaid payment suspension and being investigated for fraud. State and federal officials said disclosing those ties would have disqualified Coastal Diagnostics from participating in Medicaid.
After Coastal Diagnostics began billing Medicaid for laboratory services, the state discovered the relationship between the two companies and terminated Coastal Diagnostics’ provider agreement. The settlement covers claims submitted between March 6 and June 3, 2024.
In a separate case, Genco Lab and its owners in 2025 agreed to pay more than $1.25 million to settle allegations they submitted false claims to government health care programs for medically unnecessary urine drug tests.
The case was investigated by the U.S. Department of Health and Human Services Office of Inspector General. It is being handled by Assistant U.S. Attorney Richard M. Molot and Assistant Attorney General Christine Miller of the Connecticut Office of the Attorney General.
The settlement is part of the Justice Department’s 2026 National Health Care Fraud Takedown.
